Granite Investment Partners LLC Buys Shares of 211,030 BioLife Solutions, Inc. (NASDAQ:BLFS)

Granite Investment Partners LLC purchased a new position in shares of BioLife Solutions, Inc. (NASDAQ:BLFS) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 211,030 shares of the medical equipment provider’s stock, valued at approximately $1,205,000. Granite Investment Partners LLC owned 1.60% of BioLife Solutions as of its most recent SEC filing.

Separately, Essex Investment Management Co. LLC purchased a new position in shares of BioLife Solutions during the 3rd quarter worth $484,000. Hedge funds and other institutional investors own 9.41% of the company’s stock.

Shares of BioLife Solutions, Inc. (NASDAQ BLFS) traded up $0.15 during trading on Thursday, hitting $5.37. The company’s stock had a trading volume of 76,322 shares, compared to its average volume of 106,108. BioLife Solutions, Inc. has a one year low of $1.51 and a one year high of $7.53.

BioLife Solutions (NASDAQ:BLFS) last issued its earnings results on Thursday, November 9th. The medical equipment provider reported ($0.03) earnings per share for the quarter, topping the consensus estimate of ($0.06) by $0.03. The business had revenue of $2.96 million for the quarter, compared to analyst estimates of $2.60 million. BioLife Solutions had a negative return on equity of 49.92% and a negative net margin of 52.10%. sell-side analysts expect that BioLife Solutions, Inc. will post -0.21 earnings per share for the current year.

Separately, Maxim Group set a $7.00 price target on BioLife Solutions and gave the stock a “buy” rating in a research note on Thursday, October 19th.

COPYRIGHT VIOLATION NOTICE: This story was first posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this story on another site, it was stolen and republished in violation of U.S. and international trademark and copyright legislation. The original version of this story can be read at

BioLife Solutions Profile

BioLife Solutions, Inc (BioLife) is engaged in the developing, manufacturing and marketing a portfolio of biopreservation tools and services for cells, tissues and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud hosted biologistics cold chain management application for shippers.

Receive News & Ratings for BioLife Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioLife Solutions Inc. and related companies with's FREE daily email newsletter.

Leave a Reply